Algeta's P2P Acquisition

Algeta raised a round of funding on February 26, 2014. Investors include Bayer.

Algeta is focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, based …

Articles about Algeta's P2P Acquisition: